Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib.
about
Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Meta-analysis of the risks of ...... who were receiving vandetanib.
@en
type
label
Meta-analysis of the risks of ...... who were receiving vandetanib.
@en
prefLabel
Meta-analysis of the risks of ...... who were receiving vandetanib.
@en
P2093
P2860
P1476
Meta-analysis of the risks of ...... who were receiving vandetanib.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00228-015-1831-1
P577
2015-03-11T00:00:00Z